Original Article

Evaluation of Lactate and C-Reactive Protein in the Assessment of Acute Myocardial Infarction

Authors: Ali R. Rahimi, MD, FACP, AGSF, Peter M. Marzano, III, MD, Christian M. Richard, MSc

Abstract

Purpose The purpose of this study was to assess the usefulness of lactate and C-reactive protein as early markers of acute myocardial infarction (AMI) in conjunction with established markers, such as creatine phosphokinase (CPK)-MB and troponin I. Methods The study population consisted of all patients admitted with suspected AMI regardless of age, race, gender, or comorbid conditions. All patients in cardiac heart failure or cardiogenic shock were excluded. Lactate and C-reactive protein were drawn at admission, and then at 2 and 4 hours, respectively. The positive and negative predictive values of these markers were calculated in relation to the primary outcome measure. Results A total of 62 patients were enrolled in the study. Of those, 18 patients had documented AMI and all underwent thrombolysis, thrombolysis with angioplasty, or stent placement. The lactate was measured at 2 and 4 hours, and lactate levels correlated with CPK and CPK-MB, in addition to troponin I. In our cohort, lactate had a sensitivity of 75% and a specificity of 95.5%, with a positive predictive value of 85.7% and a negative predictive value of 91.3%. Conclusion As an inexpensive and readily available marker for AMI, lactate seems to be reliable and could be used in an emergency setting to facilitate the decision-making process for chest pain syndrome. It would be a helpful adjunct on whether the patient can be safely discharged or should be promptly admitted.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Schmiechen NJ, Han C, Milzman DP. Emergency department use of rapid lactate to evaluate patients with acute chest pain. Ann Emerg Med 1997; 30: 571–577.
 
2. Roberts R, Henry PD, Witteeveen SA, et al. Quantification of serum creatine phosphokinase isoenzyme activity. Am J Cardiol 1974; 33: 650–654.
 
3. Adams JE III, Abendschein DR, Jaffe AS. Biochemical marker of myocardial injury: Is MB creatine kinase the choice for the 1900s? Circulation 1993; 88: 750–763.
 
4. Yasmineh WG, Ibrahim GA, Abbasnezhad M, et al. Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders. Clin Chem 1978; 24: 1985–1989.
 
5. Ueda S, Ikeda U, Yamamoto K, et al. C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction. Am Heart J 1996; 131: 857–860.
 
6. Jaffe AS. More rapid biochemical diagnosis of myocardial infarction: Necessary? Prudent? Cost effective? Clin Chem 1993; 39: 1567–1569.
 
7. Lee TH, Rouan GW, Weisberg MC, et al. Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization. Ann Intern Med 1987; 106: 181–186.
 
8. Hedges JR, Rouan GW, Toltzis R, et al. Use of cardiac enzymes identifies patients with acute myocardial infarction otherwise unrecognized in the emergency department. Ann Emerg Med 1987; 16: 248–252.
 
9. Toth C, Csomos M, Vadnay I. Significance of early echocardiography in acute myocardial infarct [in Hungarian]. Orv Hetil 1997; 138: 787–791.
 
10. Selker HP, Zalenski RJ, Antman EM, et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: A report from a National Heart Attack Alert Program Working Group. Ann Emerg Med 1997; 29: 13–87.
 
11. Roberts R, Gowda KS, Ludbrook PA, et al. Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction. Am J Cardiol 1975; 36: 433–437.
 
12. Mair J, Artner-Dworzak E, Lechleitner P, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991; 37: 845–852.
 
13. Jaffe AS. New marker for myocardial infarction: Are they needed? Contemp Intern Med 1997; 9: 6–12.
 
14. Mizock BA. Lactic acidosis. Dis Mon 1989; 35: 233–300.
 
15. Bernstein WK, Aduen J, Bhatiani A, et al. Simultaneous arterial and venous lactate determination in critically ill patients. Crit Care Med 1994; 22( Suppl): A227(abstract).